Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
about
Complete genome sequence of an M1 strain of Streptococcus pyogenesInterventions for necrotizing soft tissue infections in adultsFunctional and structural properties of a novel protein and virulence factor (Protein sHIP) in Streptococcus pyogenesHyaluronic acid capsule is a virulence factor for mucoid group A streptococciStreptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expressionGram-positive bacterial superantigen outside-in signaling causes toxic shock syndromeStreptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatmentA cluster of cases of streptococcal necrotizing fasciitis in GloucestershireSequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococciStaphylococcal superantigens in colonization and diseaseThe FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells.Unique Footprint in the scl1.3 Locus Affects Adhesion and Biofilm Formation of the Invasive M3-Type Group A StreptococcusThe roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infectionsEffects of delayed NSAID administration after experimental eccentric contraction injury – A cellular and proteomics studyPathogenesis of group A streptococcal infectionsManagement and Novel Adjuncts of Necrotizing Soft Tissue Infections.Predictors of Monomicrobial Necrotizing Soft Tissue Infections.A molecular trigger for intercontinental epidemics of group A Streptococcus.Necrotizing Fasciitis on the Right Side of the Neck with Internal Jugular Vein Thrombophlebitis and Septic Emboli: A Case of Lemierre's-Like Syndrome.National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sitesA fluoroquinolone induces a novel mitogen-encoding bacteriophage in Streptococcus canis.Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunityA glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates.Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates.Cytolysins augment superantigen penetration of stratified mucosaClinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndromeRespiratory diseases among U.S. military personnel: countering emerging threats.Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.Effect of group A streptococcal cysteine protease on invasion of epithelial cells.Puerperal and intrapartum group A streptococcal infection.Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.Necrotizing soft tissue infectionsSoft tissue injury of the lower extremity complicated by type II necrotising fasciitis highlighting the need for astute clinical practices and proper treatment.Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide studyPost-partum streptococcal toxic shock syndrome associated with necrotizing fasciitis.Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and BNecrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still highThe rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production.
P2860
Q22066334-C7123FE3-7311-4A66-861F-50A166D9CBC8Q24186717-158C8C1E-17FC-46E2-A23C-C8ACAD461E5BQ24297754-339ECA4E-8A50-4086-A697-48B078CCA025Q24561897-57EDD9D5-C4F4-4236-B95E-B4E19003912EQ24563802-67F205CC-AD7C-49E7-95E0-423D3ED4F468Q24607551-7A2280B0-0D16-426B-B7A6-B4AD4555FE18Q24648318-F6589101-1275-4C72-B4BB-2FC87592E9F3Q24650424-2FBC8342-7DCA-4F88-B2FE-2D7782D3736FQ24672374-F4762E08-CB2F-4950-9171-52C8F46A2EE0Q26995577-1C36BCC4-8FCA-4874-B2F9-94A2B191946BQ27349319-83A69BC6-B012-4297-BF19-C179209B92EFQ28387917-0BBB1A5B-88F0-46B9-9ED6-399EA13A8ADAQ28388621-17E12BDC-33C4-4F97-A127-2B2C197AE92DQ29248906-C61B9168-0302-4E37-851C-83CB9FAEC3CBQ29615547-8185A917-DA93-4C3D-B4CC-767B8D38667AQ30234954-FB468985-EFBA-444A-86D5-F58C5E6EBA4AQ30279116-8578B5D8-550A-4DC9-9E44-FA72A68925C5Q30377731-904A0A9C-F2E5-4A61-8088-E8843C40EECFQ30441647-A2DEA2E0-DDB7-434F-8E05-2F8517F3D903Q30881760-484A7514-C8BB-44FA-9CC9-8D702FEE16F3Q31142982-C2D8433F-0A87-4A8A-A21C-698DFCBA7365Q33245526-0420C679-638A-4DBE-91E2-BFD314C844ABQ33279533-E1C5BC65-9015-4131-81EC-ABB49DF7B3DFQ33369063-38727118-6AC3-4946-BA22-BE0BE5B9C4CBQ33578435-F038B715-564B-49E8-B95C-12C6EEA62E19Q33585467-BBE488AD-9E2E-487B-9053-3EEF37F7E7FDQ33588900-3CEBB20B-DA36-415A-B1FE-7EC26C52AE64Q33605090-4C13A591-63B7-4763-8E9B-610E2A31B295Q33643096-84DD29B2-D615-4C0A-89CB-E2E2DF80F7A4Q33674247-CEF997E0-E25F-4530-8F0D-B52CE7A27939Q33752246-8F680AB1-7BD8-426B-9780-4A627CD3CF8FQ33794853-E834DED5-2616-4B1F-8EA6-7F95CD06C851Q33803439-46EC9374-27F7-42C2-882D-ABACFED08522Q33809033-C54E97A9-F3C5-483F-BFDC-47126C3032A1Q33833451-15BC722C-D6BE-4F2E-8797-79FFE45942CAQ33884965-F2257704-B4FF-4B68-B3B4-AE220B915ABDQ33897063-77B125EB-EBE7-4C2D-AAFF-0A6CA377BEEEQ33963450-10BE5577-EB29-4223-979A-C52A8F6CDEF4Q33990555-72E48296-30EC-49BB-9EC0-A88DA0E23E24Q34000839-EEFDB881-DDC3-42F5-9AA2-2B1FDE576504
P2860
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@ast
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@en
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@nl
type
label
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@ast
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@en
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@nl
prefLabel
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@ast
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@en
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@nl
P2093
P1476
Severe group A streptococcal i ...... ome and scarlet fever toxin A.
@en
P2093
Schlievert PM
Stevens DL
P356
10.1056/NEJM198907063210101
P407
P577
1989-07-01T00:00:00Z